1,180
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Development of human monoclonal antibodies to diphtheria toxin: A solution for the increasing lack of equine DAT for therapeutic use?

Pages 613-615 | Received 02 May 2016, Accepted 09 May 2016, Published online: 09 Jun 2016

References

  • Wagner KS, White JM, Lucenko I, Mercer D, Crowcroft NS, Neal S, Efstratiou A. Diphtheria in the postepidemic period, Europe, 2000-2009. Emerg Infect Dis 2012; 18:217–225; PMID:22304732; http://dx.doi.org/10.3201/eid1802.110987
  • Wagner KS, Stickings P, White JM, Neal S, Crowcroft NS, Sesardic D, Efstratiou A. A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use. Vaccine 2009; 28:14–20; PMID:19818425; http://dx.doi.org/10.1016/j.vaccine.2009.09.094
  • Kakita M, Takahashi T, Komiya T, Iba Y, Tsuji T, Kurosawa Y, Takahashi M. Isolation of a human monoclonal antibody with strong neutralizing activity against diphtheria toxin. Infect Immun 2006; 74:3682–3; PMID:16714603; http://dx.doi.org/10.1128/IAI.01731-05
  • Sevigny LM, Booth BJ, Rowley KJ, Leav BA, Cheslock PS, Garrity KA, Sloan SE, Thomas W, Jr., Babcock GJ, Wang Y. Identification of a human monoclonal antibody to replace equine diphtheria antitoxin for treatment of diphtheria intoxication. Infect Immun 2013; 81:3992–4000; PMID:23940209; http://dx.doi.org/10.1128/IAI.00462-13
  • Smith HL, Cheslock P, Leney M, Barton B, Molrine DC. Potency of a human monoclonal antibody to diphtheria toxin relative to equine diphtheria antitoxin in a guinea pig intoxication model. Virulence 2016; 7(x):xx-xx;PMID:27070129; http://dx.doi.org/10.1080/21505594.2016.1171436
  • Scheifele DW, Ochnio JJ. The immunological basis for immunization series/module 2: diphtheria update 2009. [pp. 1-28]; WHO.
  • Edmunds WJ, Pebody RG, Aggerback H, Baron S, Berbers G, Conyn-Van Spaendonck MA, Hallander HO, Olander R, Maple PA, Melker HE, et al. The sero-epidemiology of diphtheria in Western Europe. ESEN Project. Epidemiol Infect 2000; 125:113–25; PMID:11057967; http://dx.doi.org/10.1017/S0950268899004161
  • Theeten H, Hutse V, Hens N, Yavuz Y, Hoppenbrouwers K, Beutels P, Vranckx R, Van Damme P. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphteria and tetanus in Belgium. Epidemiol Infect 2011; 139:494–504; PMID:20587123; http://dx.doi.org/10.1017/S0950268810001536
  • Swart EM, van Gageldonk PG, de Melker HE, van der Klis FR, Berbers GA, Mollema L. Long-term protection against diphtheria in the Netherlands after 50 years of vaccination: results from a seroepidemiological study. PLoS One 2016; 11:e0148605; PMID:26863307; http://dx.doi.org/10.1371/journal.pone.0148605
  • Huygen K, Caboré RN, Maertens K, Van Damme P, Leuridan E. Humoral and cell mediated immune responses to a pertussis vaccine in pregnant and nonpregnant women. Vaccine 2015; 33:4117–23; PMID:26187257; http://dx.doi.org/10.1016/j.vaccine.2015.06.108
  • Maertens K, Caboré RN, Huygen K, Hens N, Van Damme P, Leuridan E. Pertussis vaccination during pregnancy in Belgium: Results of a prospective controlled cohort study. Vaccine 2016; 34:142–150; PMID:26592142; http://dx.doi.org/10.1016/j.vaccine.2015.10.100

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.